HEADER TRANSLATION FACTOR/ANTIBIOTIC 12-OCT-11 3U6B TITLE EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028 CAVEAT 3U6B SER C 1 HAS WRONG CHIRALITY AT ATOM CA SER D 1 HAS WRONG CAVEAT 2 3U6B CHIRALITY AT ATOM CA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION FACTOR TU 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EF-TU 1, P-43; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THIOCILLIN GE2270 ANALOGUE NVP-LDI028; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: EF-TU 1, P-43 ,EF-TU; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: TUFA, B3339, JW3301; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (STAR); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES KEYWDS TRANSLATION FACTOR-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.PALESTRANT REVDAT 4 15-NOV-23 3U6B 1 REMARK LINK ATOM REVDAT 3 29-JAN-20 3U6B 1 CAVEAT REMARK SEQADV SEQRES REVDAT 3 2 1 HETSYN LINK REVDAT 2 18-APR-12 3U6B 1 COMPND REVDAT 1 08-FEB-12 3U6B 0 JRNL AUTH M.J.LAMARCHE,J.A.LEEDS,K.AMARAL,J.T.BREWER,S.M.BUSHELL, JRNL AUTH 2 J.M.DEWHURST,J.DZINK-FOX,E.GANGL,J.GOLDOVITZ,A.JAIN, JRNL AUTH 3 S.MULLIN,G.NECKERMANN,C.OSBORNE,D.PALESTRANT,M.A.PATANE, JRNL AUTH 4 E.M.RANN,M.SACHDEVA,J.SHAO,S.TIAMFOOK,L.WHITEHEAD,D.YU JRNL TITL ANTIBACTERIAL OPTIMIZATION OF 4-AMINOTHIAZOLYL ANALOGUES OF JRNL TITL 2 THE NATURAL PRODUCT GE2270 A: IDENTIFICATION OF THE JRNL TITL 3 CYCLOALKYLCARBOXYLIC ACIDS. JRNL REF J.MED.CHEM. V. 54 8099 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21999529 JRNL DOI 10.1021/JM200938F REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.9 REMARK 3 NUMBER OF REFLECTIONS : 37531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1861 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.85 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2543 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2379 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2458 REMARK 3 BIN R VALUE (WORKING SET) : 0.2356 REMARK 3 BIN FREE R VALUE : 0.3036 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.34 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 85 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.44850 REMARK 3 B22 (A**2) : -1.55720 REMARK 3 B33 (A**2) : 3.00570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6056 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8231 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2046 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 137 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 915 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6056 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.25 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3U6B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000068360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.32200 REMARK 200 R SYM FOR SHELL (I) : 0.25700 REMARK 200 FOR SHELL : 8.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM ACETATE, 22% PEG 3350, REMARK 280 0.1M BIS-TRIS PH6.5 , VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.24150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.24150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 48.62300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.18800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 48.62300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.18800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 78.24150 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 48.62300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.18800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 78.24150 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 48.62300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.18800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 524 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 400 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 400 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 400 MODIFIED REMARK 400 REMARK 400 THE THIOCILLIN GE2270 ANALOGUE NVP-LDI028 IS THIOPEPTIDE, A MEMBER REMARK 400 OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: THIOCILLIN GE2270 ANALOGUE NVP-LDI028 REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 LYS A 2 REMARK 465 GLU A 3 REMARK 465 LYS A 4 REMARK 465 ALA A 42 REMARK 465 ALA A 43 REMARK 465 ARG A 44 REMARK 465 ALA A 45 REMARK 465 PHE A 46 REMARK 465 ASP A 47 REMARK 465 GLN A 48 REMARK 465 ILE A 49 REMARK 465 ASP A 50 REMARK 465 ASN A 51 REMARK 465 ALA A 52 REMARK 465 PRO A 53 REMARK 465 GLU A 54 REMARK 465 GLU A 55 REMARK 465 LYS A 56 REMARK 465 ALA A 57 REMARK 465 SER A 221 REMARK 465 GLY A 222 REMARK 465 ARG A 223 REMARK 465 GLY A 224 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 ARG B 44 REMARK 465 ALA B 45 REMARK 465 PHE B 46 REMARK 465 ASP B 47 REMARK 465 GLN B 48 REMARK 465 ILE B 49 REMARK 465 ASP B 50 REMARK 465 ASN B 51 REMARK 465 ALA B 52 REMARK 465 PRO B 53 REMARK 465 GLU B 54 REMARK 465 GLU B 55 REMARK 465 SER B 221 REMARK 465 GLY B 222 REMARK 465 ARG B 223 REMARK 465 GLY B 224 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER C 1 CA SER C 1 CB -0.118 REMARK 500 SER D 1 CA SER D 1 CB -0.134 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 96 74.83 -100.39 REMARK 500 ASP A 141 38.03 -96.04 REMARK 500 ILE A 247 -67.95 55.44 REMARK 500 ARG A 262 -11.67 73.79 REMARK 500 ARG A 283 -39.11 -38.41 REMARK 500 ARG A 327 73.48 -116.67 REMARK 500 ARG A 333 -70.81 58.71 REMARK 500 ARG B 7 77.05 -64.56 REMARK 500 THR B 8 13.97 -156.76 REMARK 500 ASP B 21 -0.21 71.06 REMARK 500 ARG B 58 -33.53 84.66 REMARK 500 ASP B 141 69.36 -114.41 REMARK 500 ASP B 161 -1.92 78.16 REMARK 500 GLU B 215 -68.89 -96.13 REMARK 500 ILE B 247 -65.19 57.86 REMARK 500 ARG B 262 -5.49 82.95 REMARK 500 ALA B 270 130.55 -38.54 REMARK 500 PHE B 323 -165.09 -114.42 REMARK 500 ARG B 333 -65.34 63.66 REMARK 500 MEN D 3 -167.14 -100.31 REMARK 500 VAL D 5 -24.11 -171.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 25 OG1 REMARK 620 2 GDP A 402 O2B 95.4 REMARK 620 3 HOH A 503 O 94.5 102.8 REMARK 620 4 HOH A 514 O 80.8 91.2 165.7 REMARK 620 5 HOH A 517 O 165.6 95.3 92.5 89.4 REMARK 620 6 HOH A 531 O 77.3 167.7 87.8 78.0 90.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 402 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 25 OG1 REMARK 620 2 GDP B 401 O2B 93.1 REMARK 620 3 HOH B 505 O 91.8 93.6 REMARK 620 4 HOH B 512 O 87.8 93.9 172.4 REMARK 620 5 HOH B 514 O 177.0 89.9 88.4 91.7 REMARK 620 6 HOH B 516 O 90.0 170.8 95.0 77.5 87.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF NVP-LDI028 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF NVP-LDI028 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3U6K RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDK733 REMARK 900 RELATED ID: 3U2Q RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LFF571 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 999 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 999 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 999 MODIFIED. DBREF 3U6B A 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 3U6B B 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 3U6B C 1 12 UNP Q7M0J8 THCL_PLARO 1 12 DBREF 3U6B D 1 12 UNP Q7M0J8 THCL_PLARO 1 12 SEQADV 3U6B MET A 0 UNP P0CE47 EXPRESSION TAG SEQADV 3U6B ALA A 1 UNP P0CE47 EXPRESSION TAG SEQADV 3U6B MET B 0 UNP P0CE47 EXPRESSION TAG SEQADV 3U6B ALA B 1 UNP P0CE47 EXPRESSION TAG SEQADV 3U6B 8BB C 12 UNP Q7M0J8 CYS 12 SEE REMARK 999 SEQADV 3U6B 8BB D 12 UNP Q7M0J8 CYS 12 SEE REMARK 999 SEQRES 1 A 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 A 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 A 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 A 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 A 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 A 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 A 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 A 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 A 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 A 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 A 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 A 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 A 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 A 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 A 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 A 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 A 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 A 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 A 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 A 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 A 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 A 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 A 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 A 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 A 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 A 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 A 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 A 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 A 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 A 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 A 394 LYS VAL LEU GLY SEQRES 1 B 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 B 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 B 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 B 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 B 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 B 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 B 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 B 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 B 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 B 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 B 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 B 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 B 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 B 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 B 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 B 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 B 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 B 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 B 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 B 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 B 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 B 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 B 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 B 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 B 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 B 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 B 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 B 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 B 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 B 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 B 394 LYS VAL LEU GLY SEQRES 1 C 12 SER BB9 MEN BB6 VAL BB7 GLY BB8 BB9 BB9 MH6 8BB SEQRES 1 D 12 SER BB9 MEN BB6 VAL BB7 GLY BB8 BB9 BB9 MH6 8BB MODRES 3U6B BB9 C 2 CYS MODRES 3U6B MEN C 3 ASN N-METHYL ASPARAGINE MODRES 3U6B BB6 C 4 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 3U6B BB7 C 6 CYS MODRES 3U6B BB8 C 8 PHE (2S,3S)-BETA-HYDROXY-PHENYLALANINE MODRES 3U6B BB9 C 9 CYS MODRES 3U6B BB9 C 10 CYS MODRES 3U6B MH6 C 11 SER 3-HYDROXY-2-IMINOPROPANOIC ACID MODRES 3U6B BB9 D 2 CYS MODRES 3U6B MEN D 3 ASN N-METHYL ASPARAGINE MODRES 3U6B BB6 D 4 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 3U6B BB7 D 6 CYS MODRES 3U6B BB8 D 8 PHE (2S,3S)-BETA-HYDROXY-PHENYLALANINE MODRES 3U6B BB9 D 9 CYS MODRES 3U6B BB9 D 10 CYS MODRES 3U6B MH6 D 11 SER 3-HYDROXY-2-IMINOPROPANOIC ACID HET BB9 C 2 6 HET MEN C 3 8 HET BB6 C 4 7 HET BB7 C 6 9 HET BB8 C 8 11 HET BB9 C 9 5 HET BB9 C 10 5 HET MH6 C 11 4 HET 8BB C 12 16 HET BB9 D 2 6 HET MEN D 3 8 HET BB6 D 4 7 HET BB7 D 6 9 HET BB8 D 8 11 HET BB9 D 9 5 HET BB9 D 10 5 HET MH6 D 11 4 HET 8BB D 12 16 HET MG A 401 1 HET GDP A 402 28 HET GDP B 401 28 HET MG B 402 1 HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM MEN N-METHYL ASPARAGINE HETNAM BB6 (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB7 (2Z)-2-AMINO-4-METHOXY-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB8 (2S,3S)-BETA-HYDROXY-PHENYLALANINE HETNAM MH6 3-HYDROXY-2-IMINOPROPANOIC ACID HETNAM 8BB TRANS-4-{[(E)-1-AMINO-2- HETNAM 2 8BB SULFANYLETHENYL]CARBAMOYL}CYCLOHEXANECARBOXYLIC ACID HETNAM MG MAGNESIUM ION HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETSYN BB8 BETA-HYDROXY-PHENYLALANINE; THREO-BETA-HYDROXY-L- HETSYN 2 BB8 PHENYLALANINE; (BETAS)-BETA-HYDROXY-L-PHENYLALANINE; HETSYN 3 BB8 L-THREO-3-PHENYLSERINE; L-THREO-BETA-PHENYLSERINE; 3- HETSYN 4 BB8 HYDROXY-L-PHENYLALANINE FORMUL 3 BB9 6(C3 H5 N O2 S) FORMUL 3 MEN 2(C5 H10 N2 O3) FORMUL 3 BB6 2(C4 H7 N O2 S) FORMUL 3 BB7 2(C5 H9 N O3 S) FORMUL 3 BB8 2(C9 H11 N O3) FORMUL 3 MH6 2(C3 H5 N O3) FORMUL 3 8BB 2(C10 H16 N2 O3 S) FORMUL 5 MG 2(MG 2+) FORMUL 6 GDP 2(C10 H15 N5 O11 P2) FORMUL 9 HOH *111(H2 O) HELIX 1 1 GLY A 23 TYR A 39 1 17 HELIX 2 2 GLY A 83 GLY A 94 1 12 HELIX 3 3 MET A 112 GLY A 126 1 15 HELIX 4 4 ASP A 142 TYR A 160 1 19 HELIX 5 5 PRO A 163 THR A 167 5 5 HELIX 6 6 SER A 173 GLU A 179 1 7 HELIX 7 7 ASP A 181 ILE A 199 1 19 HELIX 8 8 ARG A 204 LYS A 208 5 5 HELIX 9 9 LYS A 282 ILE A 286 5 5 HELIX 10 10 SER A 312 GLY A 316 5 5 HELIX 11 11 GLU B 3 ARG B 7 1 5 HELIX 12 12 GLY B 23 GLY B 40 1 18 HELIX 13 13 GLY B 83 GLY B 94 1 12 HELIX 14 14 MET B 112 VAL B 125 1 14 HELIX 15 15 ASP B 142 TYR B 160 1 19 HELIX 16 16 PRO B 163 THR B 167 5 5 HELIX 17 17 SER B 173 GLU B 179 1 7 HELIX 18 18 ASP B 181 ILE B 199 1 19 HELIX 19 19 ARG B 204 LYS B 208 5 5 HELIX 20 20 LYS B 282 ILE B 286 5 5 HELIX 21 21 SER B 312 GLY B 316 5 5 SHEET 1 A 6 SER A 65 ASP A 70 0 SHEET 2 A 6 HIS A 75 ASP A 80 -1 O HIS A 78 N VAL A 67 SHEET 3 A 6 HIS A 11 ILE A 17 1 N VAL A 14 O ALA A 77 SHEET 4 A 6 GLY A 100 ALA A 106 1 O ILE A 102 N GLY A 15 SHEET 5 A 6 ILE A 130 ASN A 135 1 O ASN A 135 N VAL A 105 SHEET 6 A 6 ILE A 169 ARG A 171 1 O VAL A 170 N LEU A 134 SHEET 1 B 7 LEU A 211 PRO A 213 0 SHEET 2 B 7 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 B 7 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 B 7 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 B 7 ASN A 273 LEU A 278 -1 O LEU A 277 N THR A 256 SHEET 6 B 7 VAL A 226 ARG A 230 -1 N VAL A 227 O VAL A 276 SHEET 7 B 7 VAL A 217 PHE A 218 -1 N PHE A 218 O VAL A 226 SHEET 1 C 5 LEU A 211 PRO A 213 0 SHEET 2 C 5 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 C 5 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 C 5 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 C 5 LYS A 263 LEU A 265 -1 O LEU A 265 N VAL A 258 SHEET 1 D 2 ILE A 235 LYS A 237 0 SHEET 2 D 2 GLU A 267 ARG A 269 -1 O GLY A 268 N ILE A 236 SHEET 1 E 7 LYS A 299 ILE A 310 0 SHEET 2 E 7 ASN A 355 MET A 368 -1 O LEU A 362 N THR A 302 SHEET 3 E 7 THR A 335 GLU A 342 -1 N THR A 340 O THR A 361 SHEET 4 E 7 GLN A 329 PHE A 332 -1 N PHE A 330 O VAL A 337 SHEET 5 E 7 ARG A 373 GLU A 378 -1 O ARG A 377 N GLN A 329 SHEET 6 E 7 ARG A 381 GLY A 393 -1 O GLY A 384 N ILE A 376 SHEET 7 E 7 LYS A 299 ILE A 310 -1 N GLU A 305 O LYS A 390 SHEET 1 F 2 PHE A 322 PHE A 323 0 SHEET 2 F 2 MET A 349 VAL A 350 -1 O VAL A 350 N PHE A 322 SHEET 1 G 6 SER B 65 ASP B 70 0 SHEET 2 G 6 HIS B 75 ASP B 80 -1 O HIS B 78 N VAL B 67 SHEET 3 G 6 HIS B 11 ILE B 17 1 N VAL B 14 O ALA B 77 SHEET 4 G 6 GLY B 100 ALA B 106 1 O VAL B 104 N ILE B 17 SHEET 5 G 6 ILE B 130 ASN B 135 1 O ILE B 131 N LEU B 103 SHEET 6 G 6 ILE B 169 ARG B 171 1 O VAL B 170 N LEU B 134 SHEET 1 H 7 LEU B 211 PRO B 213 0 SHEET 2 H 7 VAL B 291 ALA B 293 -1 O LEU B 292 N LEU B 212 SHEET 3 H 7 GLU B 241 VAL B 245 -1 N GLU B 243 O ALA B 293 SHEET 4 H 7 GLN B 251 MET B 260 -1 O SER B 253 N VAL B 242 SHEET 5 H 7 ASN B 273 ARG B 279 -1 O LEU B 277 N THR B 256 SHEET 6 H 7 VAL B 226 ARG B 230 -1 N GLY B 229 O VAL B 274 SHEET 7 H 7 VAL B 217 PHE B 218 -1 N PHE B 218 O VAL B 226 SHEET 1 I 5 LEU B 211 PRO B 213 0 SHEET 2 I 5 VAL B 291 ALA B 293 -1 O LEU B 292 N LEU B 212 SHEET 3 I 5 GLU B 241 VAL B 245 -1 N GLU B 243 O ALA B 293 SHEET 4 I 5 GLN B 251 MET B 260 -1 O SER B 253 N VAL B 242 SHEET 5 I 5 LYS B 263 LEU B 265 -1 O LEU B 265 N VAL B 258 SHEET 1 J 2 ILE B 235 LYS B 237 0 SHEET 2 J 2 GLU B 267 ARG B 269 -1 O GLY B 268 N ILE B 236 SHEET 1 K 7 LYS B 299 ILE B 310 0 SHEET 2 K 7 ASN B 355 MET B 368 -1 O ILE B 356 N VAL B 308 SHEET 3 K 7 THR B 335 GLU B 342 -1 N THR B 340 O THR B 361 SHEET 4 K 7 GLN B 329 PHE B 332 -1 N PHE B 330 O VAL B 337 SHEET 5 K 7 ARG B 373 GLU B 378 -1 O ALA B 375 N TYR B 331 SHEET 6 K 7 ARG B 381 VAL B 391 -1 O GLY B 384 N ILE B 376 SHEET 7 K 7 LYS B 299 ILE B 310 -1 N GLU B 305 O LYS B 390 LINK C SER C 1 N BB9 C 2 1555 1555 1.36 LINK C SER C 1 SG BB9 C 2 1555 1555 1.77 LINK CA SER C 1 C BB9 C 10 1555 1555 1.42 LINK CB SER C 1 CB MH6 C 11 1555 1555 1.40 LINK C BB9 C 2 N MEN C 3 1555 1555 1.35 LINK C MEN C 3 SG BB6 C 4 1555 1555 1.75 LINK C MEN C 3 N BB6 C 4 1555 1555 1.33 LINK C BB6 C 4 N VAL C 5 1555 1555 1.35 LINK C VAL C 5 SG BB7 C 6 1555 1555 1.75 LINK C VAL C 5 N BB7 C 6 1555 1555 1.34 LINK C BB7 C 6 N GLY C 7 1555 1555 1.35 LINK C GLY C 7 N BB8 C 8 1555 1555 1.34 LINK C BB8 C 8 N BB9 C 9 1555 1555 1.31 LINK C BB8 C 8 SG BB9 C 9 1555 1555 1.76 LINK C BB9 C 9 N BB9 C 10 1555 1555 1.33 LINK C BB9 C 9 SG BB9 C 10 1555 1555 1.77 LINK C BB9 C 10 N MH6 C 11 1555 1555 1.35 LINK C MH6 C 11 N 8BB C 12 1555 1555 1.34 LINK C MH6 C 11 SG 8BB C 12 1555 1555 1.76 LINK C SER D 1 N BB9 D 2 1555 1555 1.34 LINK C SER D 1 SG BB9 D 2 1555 1555 1.76 LINK CA SER D 1 C BB9 D 10 1555 1555 1.42 LINK CB SER D 1 CB MH6 D 11 1555 1555 1.39 LINK C BB9 D 2 N MEN D 3 1555 1555 1.33 LINK C MEN D 3 SG BB6 D 4 1555 1555 1.74 LINK C MEN D 3 N BB6 D 4 1555 1555 1.32 LINK C BB6 D 4 N VAL D 5 1555 1555 1.35 LINK C VAL D 5 SG BB7 D 6 1555 1555 1.76 LINK C VAL D 5 N BB7 D 6 1555 1555 1.34 LINK C BB7 D 6 N GLY D 7 1555 1555 1.35 LINK C GLY D 7 N BB8 D 8 1555 1555 1.34 LINK C BB8 D 8 N BB9 D 9 1555 1555 1.31 LINK C BB8 D 8 SG BB9 D 9 1555 1555 1.77 LINK C BB9 D 9 N BB9 D 10 1555 1555 1.34 LINK C BB9 D 9 SG BB9 D 10 1555 1555 1.75 LINK C BB9 D 10 N MH6 D 11 1555 1555 1.35 LINK C MH6 D 11 N 8BB D 12 1555 1555 1.34 LINK C MH6 D 11 SG 8BB D 12 1555 1555 1.77 LINK OG1 THR A 25 MG MG A 401 1555 1555 2.09 LINK MG MG A 401 O2B GDP A 402 1555 1555 1.97 LINK MG MG A 401 O HOH A 503 1555 1555 2.01 LINK MG MG A 401 O HOH A 514 1555 1555 1.97 LINK MG MG A 401 O HOH A 517 1555 1555 2.16 LINK MG MG A 401 O HOH A 531 1555 1555 2.24 LINK OG1 THR B 25 MG MG B 402 1555 1555 1.97 LINK O2B GDP B 401 MG MG B 402 1555 1555 2.10 LINK MG MG B 402 O HOH B 505 1555 1555 2.03 LINK MG MG B 402 O HOH B 512 1555 1555 2.00 LINK MG MG B 402 O HOH B 514 1555 1555 2.20 LINK MG MG B 402 O HOH B 516 1555 1555 2.14 CISPEP 1 ALA B 95 ALA B 96 0 3.72 SITE 1 AC1 6 THR A 25 GDP A 402 HOH A 503 HOH A 514 SITE 2 AC1 6 HOH A 517 HOH A 531 SITE 1 AC2 18 ASP A 21 HIS A 22 GLY A 23 LYS A 24 SITE 2 AC2 18 THR A 25 THR A 26 ASN A 135 LYS A 136 SITE 3 AC2 18 ASP A 138 MET A 139 SER A 173 ALA A 174 SITE 4 AC2 18 LEU A 175 MG A 401 HOH A 514 HOH A 517 SITE 5 AC2 18 HOH A 554 HOH A 562 SITE 1 AC3 20 HIS B 19 ASP B 21 HIS B 22 GLY B 23 SITE 2 AC3 20 LYS B 24 THR B 25 THR B 26 ASN B 135 SITE 3 AC3 20 LYS B 136 ASP B 138 MET B 139 SER B 173 SITE 4 AC3 20 ALA B 174 LEU B 175 MG B 402 HOH B 505 SITE 5 AC3 20 HOH B 509 HOH B 512 HOH B 514 HOH B 515 SITE 1 AC4 6 THR B 25 GDP B 401 HOH B 505 HOH B 512 SITE 2 AC4 6 HOH B 514 HOH B 516 SITE 1 AC5 17 GLU B 143 GLU B 215 ASP B 216 PHE B 218 SITE 2 AC5 17 VAL B 226 THR B 228 THR B 256 GLY B 257 SITE 3 AC5 17 GLU B 259 PHE B 261 ARG B 262 ARG B 269 SITE 4 AC5 17 ASN B 273 VAL B 274 GLY B 275 LEU B 277 SITE 5 AC5 17 HOH C 101 SITE 1 AC6 17 GLU A 143 ILE A 206 GLU A 215 ASP A 216 SITE 2 AC6 17 PHE A 218 THR A 228 THR A 256 GLY A 257 SITE 3 AC6 17 GLU A 259 MET A 260 PHE A 261 ARG A 262 SITE 4 AC6 17 ARG A 269 ASN A 273 VAL A 274 GLY A 275 SITE 5 AC6 17 LEU A 277 CRYST1 97.246 100.376 156.483 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010283 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009963 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006390 0.00000